Lentivirus and AAV Transfection Reagent - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511247642

Publication Date:

November 22, 2024

Pages:

131

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Lentivirus transfection reagent is designed to enhance delivery of packaging and transfer vector DNA to suspension and adherent HEK 293 cell types in order to increase production of adeno-associated virus (AAV) and lentivirus.
The global market for Lentivirus and AAV Transfection Reagent was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Lentivirus and AAV Transfection Reagent was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lentivirus and AAV Transfection Reagent was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Lentivirus and AAV Transfection Reagent was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Lentivirus and AAV Transfection Reagent include Mirus Bio, Thermo Fisher Scientific, Polyplus-transfection, Takara Bio, GeneMedi, SignaGen Laboratories, Roche, Invitrogen and System Bioscience, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lentivirus and AAV Transfection Reagent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lentivirus and AAV Transfection Reagent by region & country, by Type, and by Application.
The Lentivirus and AAV Transfection Reagent market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lentivirus and AAV Transfection Reagent.
麻豆原创 Segmentation
By Company
Mirus Bio
Thermo Fisher Scientific
Polyplus-transfection
Takara Bio
GeneMedi
SignaGen Laboratories
Roche
Invitrogen
System Bioscience
WZ Biosciences
Inovogen Tech
Segment by Type:
AAV
Lentivirus
Complex
Segment by Application
Laboratory
Hospital
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Lentivirus and AAV Transfection Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Lentivirus and AAV Transfection Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Lentivirus and AAV Transfection Reagent in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Lentivirus and AAV Transfection Reagent Product Introduction
1.2 Global Lentivirus and AAV Transfection Reagent 麻豆原创 Size Forecast
1.2.1 Global Lentivirus and AAV Transfection Reagent Sales Value (2019-2030)
1.2.2 Global Lentivirus and AAV Transfection Reagent Sales Volume (2019-2030)
1.2.3 Global Lentivirus and AAV Transfection Reagent Sales Price (2019-2030)
1.3 Lentivirus and AAV Transfection Reagent 麻豆原创 Trends & Drivers
1.3.1 Lentivirus and AAV Transfection Reagent Industry Trends
1.3.2 Lentivirus and AAV Transfection Reagent 麻豆原创 Drivers & Opportunity
1.3.3 Lentivirus and AAV Transfection Reagent 麻豆原创 Challenges
1.3.4 Lentivirus and AAV Transfection Reagent 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lentivirus and AAV Transfection Reagent Players Revenue Ranking (2023)
2.2 Global Lentivirus and AAV Transfection Reagent Revenue by Company (2019-2024)
2.3 Global Lentivirus and AAV Transfection Reagent Players Sales Volume Ranking (2023)
2.4 Global Lentivirus and AAV Transfection Reagent Sales Volume by Company Players (2019-2024)
2.5 Global Lentivirus and AAV Transfection Reagent Average Price by Company (2019-2024)
2.6 Key Manufacturers Lentivirus and AAV Transfection Reagent Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Lentivirus and AAV Transfection Reagent Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Lentivirus and AAV Transfection Reagent
2.9 Lentivirus and AAV Transfection Reagent 麻豆原创 Competitive Analysis
2.9.1 Lentivirus and AAV Transfection Reagent 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Lentivirus and AAV Transfection Reagent Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lentivirus and AAV Transfection Reagent as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 AAV
3.1.2 Lentivirus
3.1.3 Complex
3.2 Global Lentivirus and AAV Transfection Reagent Sales Value by Type
3.2.1 Global Lentivirus and AAV Transfection Reagent Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Lentivirus and AAV Transfection Reagent Sales Value, by Type (2019-2030)
3.2.3 Global Lentivirus and AAV Transfection Reagent Sales Value, by Type (%) (2019-2030)
3.3 Global Lentivirus and AAV Transfection Reagent Sales Volume by Type
3.3.1 Global Lentivirus and AAV Transfection Reagent Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Lentivirus and AAV Transfection Reagent Sales Volume, by Type (2019-2030)
3.3.3 Global Lentivirus and AAV Transfection Reagent Sales Volume, by Type (%) (2019-2030)
3.4 Global Lentivirus and AAV Transfection Reagent Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory
4.1.2 Hospital
4.2 Global Lentivirus and AAV Transfection Reagent Sales Value by Application
4.2.1 Global Lentivirus and AAV Transfection Reagent Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Lentivirus and AAV Transfection Reagent Sales Value, by Application (2019-2030)
4.2.3 Global Lentivirus and AAV Transfection Reagent Sales Value, by Application (%) (2019-2030)
4.3 Global Lentivirus and AAV Transfection Reagent Sales Volume by Application
4.3.1 Global Lentivirus and AAV Transfection Reagent Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Lentivirus and AAV Transfection Reagent Sales Volume, by Application (2019-2030)
4.3.3 Global Lentivirus and AAV Transfection Reagent Sales Volume, by Application (%) (2019-2030)
4.4 Global Lentivirus and AAV Transfection Reagent Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Lentivirus and AAV Transfection Reagent Sales Value by Region
5.1.1 Global Lentivirus and AAV Transfection Reagent Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Lentivirus and AAV Transfection Reagent Sales Value by Region (2019-2024)
5.1.3 Global Lentivirus and AAV Transfection Reagent Sales Value by Region (2025-2030)
5.1.4 Global Lentivirus and AAV Transfection Reagent Sales Value by Region (%), (2019-2030)
5.2 Global Lentivirus and AAV Transfection Reagent Sales Volume by Region
5.2.1 Global Lentivirus and AAV Transfection Reagent Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Lentivirus and AAV Transfection Reagent Sales Volume by Region (2019-2024)
5.2.3 Global Lentivirus and AAV Transfection Reagent Sales Volume by Region (2025-2030)
5.2.4 Global Lentivirus and AAV Transfection Reagent Sales Volume by Region (%), (2019-2030)
5.3 Global Lentivirus and AAV Transfection Reagent Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
5.4.2 North America Lentivirus and AAV Transfection Reagent Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
5.5.2 Europe Lentivirus and AAV Transfection Reagent Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
5.6.2 Asia Pacific Lentivirus and AAV Transfection Reagent Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
5.7.2 South America Lentivirus and AAV Transfection Reagent Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
5.8.2 Middle East & Africa Lentivirus and AAV Transfection Reagent Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lentivirus and AAV Transfection Reagent Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Lentivirus and AAV Transfection Reagent Sales Value
6.2.1 Key Countries/Regions Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
6.2.2 Key Countries/Regions Lentivirus and AAV Transfection Reagent Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
6.3.2 United States Lentivirus and AAV Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Lentivirus and AAV Transfection Reagent Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
6.4.2 Europe Lentivirus and AAV Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Lentivirus and AAV Transfection Reagent Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
6.5.2 China Lentivirus and AAV Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.5.3 China Lentivirus and AAV Transfection Reagent Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
6.6.2 Japan Lentivirus and AAV Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Lentivirus and AAV Transfection Reagent Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
6.7.2 South Korea Lentivirus and AAV Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Lentivirus and AAV Transfection Reagent Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
6.8.2 Southeast Asia Lentivirus and AAV Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Lentivirus and AAV Transfection Reagent Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Lentivirus and AAV Transfection Reagent Sales Value, 2019-2030
6.9.2 India Lentivirus and AAV Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.9.3 India Lentivirus and AAV Transfection Reagent Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Mirus Bio
7.1.1 Mirus Bio Company Information
7.1.2 Mirus Bio Introduction and Business Overview
7.1.3 Mirus Bio Lentivirus and AAV Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Mirus Bio Lentivirus and AAV Transfection Reagent Product Offerings
7.1.5 Mirus Bio Recent Development
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Information
7.2.2 Thermo Fisher Scientific Introduction and Business Overview
7.2.3 Thermo Fisher Scientific Lentivirus and AAV Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Thermo Fisher Scientific Lentivirus and AAV Transfection Reagent Product Offerings
7.2.5 Thermo Fisher Scientific Recent Development
7.3 Polyplus-transfection
7.3.1 Polyplus-transfection Company Information
7.3.2 Polyplus-transfection Introduction and Business Overview
7.3.3 Polyplus-transfection Lentivirus and AAV Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Polyplus-transfection Lentivirus and AAV Transfection Reagent Product Offerings
7.3.5 Polyplus-transfection Recent Development
7.4 Takara Bio
7.4.1 Takara Bio Company Information
7.4.2 Takara Bio Introduction and Business Overview
7.4.3 Takara Bio Lentivirus and AAV Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Takara Bio Lentivirus and AAV Transfection Reagent Product Offerings
7.4.5 Takara Bio Recent Development
7.5 GeneMedi
7.5.1 GeneMedi Company Information
7.5.2 GeneMedi Introduction and Business Overview
7.5.3 GeneMedi Lentivirus and AAV Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.5.4 GeneMedi Lentivirus and AAV Transfection Reagent Product Offerings
7.5.5 GeneMedi Recent Development
7.6 SignaGen Laboratories
7.6.1 SignaGen Laboratories Company Information
7.6.2 SignaGen Laboratories Introduction and Business Overview
7.6.3 SignaGen Laboratories Lentivirus and AAV Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.6.4 SignaGen Laboratories Lentivirus and AAV Transfection Reagent Product Offerings
7.6.5 SignaGen Laboratories Recent Development
7.7 Roche
7.7.1 Roche Company Information
7.7.2 Roche Introduction and Business Overview
7.7.3 Roche Lentivirus and AAV Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Roche Lentivirus and AAV Transfection Reagent Product Offerings
7.7.5 Roche Recent Development
7.8 Invitrogen
7.8.1 Invitrogen Company Information
7.8.2 Invitrogen Introduction and Business Overview
7.8.3 Invitrogen Lentivirus and AAV Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Invitrogen Lentivirus and AAV Transfection Reagent Product Offerings
7.8.5 Invitrogen Recent Development
7.9 System Bioscience
7.9.1 System Bioscience Company Information
7.9.2 System Bioscience Introduction and Business Overview
7.9.3 System Bioscience Lentivirus and AAV Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.9.4 System Bioscience Lentivirus and AAV Transfection Reagent Product Offerings
7.9.5 System Bioscience Recent Development
7.10 WZ Biosciences
7.10.1 WZ Biosciences Company Information
7.10.2 WZ Biosciences Introduction and Business Overview
7.10.3 WZ Biosciences Lentivirus and AAV Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.10.4 WZ Biosciences Lentivirus and AAV Transfection Reagent Product Offerings
7.10.5 WZ Biosciences Recent Development
7.11 Inovogen Tech
7.11.1 Inovogen Tech Company Information
7.11.2 Inovogen Tech Introduction and Business Overview
7.11.3 Inovogen Tech Lentivirus and AAV Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Inovogen Tech Lentivirus and AAV Transfection Reagent Product Offerings
7.11.5 Inovogen Tech Recent Development
8 Industry Chain Analysis
8.1 Lentivirus and AAV Transfection Reagent Industrial Chain
8.2 Lentivirus and AAV Transfection Reagent Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lentivirus and AAV Transfection Reagent Sales Model
8.5.2 Sales Channel
8.5.3 Lentivirus and AAV Transfection Reagent Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Mirus Bio
Thermo Fisher Scientific
Polyplus-transfection
Takara Bio
GeneMedi
SignaGen Laboratories
Roche
Invitrogen
System Bioscience
WZ Biosciences
Inovogen Tech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.